Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1996;27:1386-1392

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haring, H.-P.
Right arrow Articles by Eppihimer, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haring, H.-P.
Right arrow Articles by Eppihimer, M. J

(Stroke. 1996;27:1386-1392.)
© 1996 American Heart Association, Inc.


Articles

E-Selectin Appears in Nonischemic Tissue During Experimental Focal Cerebral Ischemia

Hans-Peter Haring, MD; Ellen L. Berg, PhD; Naoya Tsurushita, PhD; Masafumi Tagaya, MD Gregory J. del Zoppo, MD

the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla (H.-P.H., M.T., G.J. del Z.), and Protein Design Labs, Inc, Mountain View (E.L.B., N.T.), Calif.

Correspondence to Gregory J. del Zoppo, MD, Department of Molecular and Experimental Medicine, SBR17, The Scripps Research Institute, 10666 N Torrey Pines Rd, La Jolla, CA 92037.

Background and Purpose E-selectin participates in leukocyte-endothelial adhesion and the inflammatory processes that follow focal cerebral ischemia and reperfusion. The temporal and topographical patterns of microvascular E-selectin presentation after experimental focal cerebral ischemia are relevant to microvascular reactivity to ischemia.

Methods The upregulation and fate of E-selectin antigen during 2 hours of middle cerebral artery occlusion (n=4) and 3 hours of occlusion with reperfusion (1 hour, n=4; 4 hours, n=6; 24 hours, n=6) were evaluated in the nonhuman primate. E-selectin and E:P-selectin immunoreactivities were semiquantitated with the use of computerized light microscopy video imaging and laser confocal microscopy.

Results Three patterns of microvascular E-selectin expression, defined by the antibody E-1E4, were confirmed by complete elimination of E-1E4 binding after incubation with soluble recombinant human E-selectin: (1) Low immunoperoxidase intensity was observed in ischemic microvessels at 2 hours of occlusion extending to 4 hours of reperfusion (E-selectin/laminin=0.32±0.10). (2) A significant fraction of ischemic microvessels displayed high-intensity E-selectin signal by 24 hours of reperfusion (0.61±0.17) compared with control and nonischemic tissues (2P<.003). (3) In the contralateral nonischemic basal ganglia and other nonischemic tissues, low but significant E-selectin levels appeared by 24 hours of reperfusion (2P=.0005). The latter were further confirmed by an E:P-selectin immunoprobe.

Conclusions E-selectin antigen is distinctively and significantly upregulated in nonhuman primate brain after focal ischemia and reperfusion. The late appearance of E-selectin in nonischemic cerebral tissues suggests stimulation by transferable factors generated during brain injury.

Editorial Comment

Michael J Eppihimer, PhD, Guest Editor

Department of Physiology, Louisiana State University Medical Center, Shreveport, La




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. J. del Zoppo and R. Milner
Integrin-Matrix Interactions in the Cerebral Microvasculature
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1966 - 1975.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Mocco, T. Choudhri, J. Huang, E. Harfeldt, L. Efros, C. Klingbeil, V. Vexler, W. Hall, Y. Zhang, W. Mack, et al.
HuEP5C7 as a Humanized Monoclonal Anti-E/P-Selectin Neurovascular Protective Strategy in a Blinded Placebo-Controlled Trial of Nonhuman Primate Stroke
Circ. Res., November 15, 2002; 91(10): 907 - 914.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C.J.M. Frijns and L.J. Kappelle
Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease
Stroke, August 1, 2002; 33(8): 2115 - 2122.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. J. del Zoppo, K. J. Becker, and J. M. Hallenbeck
Inflammation After Stroke: Is It Harmful?
Arch Neurol, April 1, 2001; 58(4): 669 - 672.
[Full Text] [PDF]


Home page
StrokeHome page
J. Huang, T. F. Choudhri, C. J. Winfree, R. A. McTaggart, S. Kiss, J. Mocco, L. J. Kim, T. S. Protopsaltis, Y. Zhang, D. J. Pinsky, et al.
Postischemic Cerebrovascular E-Selectin Expression Mediates Tissue Injury in Murine Stroke Editorial Comment
Stroke, December 1, 2000; 31(12): 3047 - 3053.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Lipton
Ischemic Cell Death in Brain Neurons
Physiol Rev, October 1, 1999; 79(4): 1431 - 1568.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Bitsch, W. Klene, L. Murtada, H. Prange, and P. Rieckmann
A Longitudinal Prospective Study of Soluble Adhesion Molecules in Acute Stroke
Stroke, October 1, 1998; 29(10): 2129 - 2135.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Melrose, N. Tsurushita, G. Liu, and E. L. Berg
IFN-{gamma} Inhibits Activation-Induced Expression of E- and P-Selectin on Endothelial Cells
J. Immunol., September 1, 1998; 161(5): 2457 - 2464.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G. J DEL ZOPPO, R. VON KUMMER, and G. F HAMANN
Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke
J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 1 - 9.
[Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Pantoni, C. Sarti, and D. Inzitari
Cytokines and Cell Adhesion Molecules in Cerebral Ischemia : Experimental Bases and Therapeutic Perspectives
Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 503 - 513.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-Y. He, Z. Xu, J. Melrose, A. Mullowney, M. Vasquez, C. Queen, V. Vexler, C. Klingbeil, M. S. Co, and E. L. Berg
Humanization and Pharmacokinetics of a Monoclonal Antibody with Specificity for Both E- and P-Selectin
J. Immunol., January 15, 1998; 160(2): 1029 - 1035.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C.J.M. Frijns, L.J. Kappelle, J. v. Gijn, H.K. Nieuwenhuis, J.J. Sixma, and R. Fijnheer
Soluble Adhesion Molecules Reflect Endothelial Cell Activation in Ischemic Stroke and in Carotid Atherosclerosis
Stroke, November 1, 1997; 28(11): 2214 - 2218.
[Abstract] [Full Text]


Home page
CirculationHome page
C. Wayne Smith
Potential Significance of Circulating E-Selectin
Circulation, April 15, 1997; 95(8): 1986 - 1988.
[Full Text]


Home page
StrokeHome page
X. Wang, F. C. Barone, N. V. Aiyar, G. Z. Feuerstein, and G. J. del Zoppo
Interleukin-1 Receptor and Receptor Antagonist Gene Expression After Focal Stroke in Rats
Stroke, January 1, 1997; 28(1): 155 - 162.
[Abstract] [Full Text]